Dr. Wadhwani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
675 N Saint Clair St
18th Floor
Chicago, IL 60611Phone+1 312-695-0596Fax+1 312-695-4741- Is this information wrong?
Summary
- Dr. Shikha Wadhwani is Director of the Glomerular Disease Program at Northwestern University's Feinberg School of Medicine and an Assistant professor in the Division of Nephrology and Hypertension. She is also Program Director for the Glomerular disease fellowship and cofounder of the joint Rheum-Renal Lupus Nephritis clinic at Northwestern. She is committed to providing comprehensive care to patients, and has a clinical interest in glomerulonephritis, vasculitis, and pregnancy-related kidney disease. Her research focuses on clinical outcomes of glomerular diseases in the NIH-funded CureGN cohort. She is site PI/Co-I for clinical trials aimed at investigating novel therapeutics for patients with glomerular disease. She has served on numerous medical advisory boards and spoken in various regional, national, and international forums about lupus nephritis and IgA nephropathy.
Education & Training
- Ohio State University Wexner Medical CenterFellowship in Glomerular Diseases, 2016 - 2017
- Rush University Medical CenterFellowship, Nephrology, 2013 - 2016
- Rush UniversityMS, Clinical Research , 2013 - 2016
- Rush University Medical CenterResidency, Internal Medicine, 2011 - 2013
- Cook County Health and Hospitals SystemInternship, Internal Medicine, 2010 - 2011
- Rush Medical College of Rush University Medical CenterClass of 2010
Certifications & Licensure
- IL State Medical License 2011 - 2026
- OH State Medical License 2016 - 2017
Clinical Trials
- An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis Start of enrollment: 2019 Jul 15
- Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy Start of enrollment: 2018 Sep 05
- Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE) Start of enrollment: 2020 Nov 14
- Join now to see all
Publications & Presentations
PubMed
- CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes.Amy K Mottl, Andrew S Bomback, Laura H Mariani, Gaia Coppock, J Charles Jennette, Salem Almaani, Debbie S Gipson, Sara Kelley, Jason Kidd, Louis-Philippe Laurin, Krzys...> ;Glomerular Diseases. 2023 Jun 26
- 6 citationsKDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases.Laurence H Beck Jr, Isabelle Ayoub, Dawn Caster, Michael J Choi, Jason Cobb, Duvuru Geetha, Michelle N Rheault, Shikha Wadhwani, Timothy Yau, William L Whittier> ;American Journal of Kidney Diseases. 2023 Aug 1
- Pregnancy History and Kidney Disease Progression Among Women Enrolled in Cure Glomerulonephropathy.Monica L Reynolds, Andrea L Oliverio, Jarcy Zee, Elizabeth M Hendren, Michelle M O'Shaughnessy, Isabelle Ayoub, Salem Almaani, Tetyana L Vasylyeva, Katherine E Twomble...> ;Kidney International Reports. 2023 Apr 1
- Join now to see all
Professional Memberships
- Member
Other Languages
- Hindi
Hospital Affiliations
- Northwestern Memorial HospitalChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: